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Abstract
Background: The purpose of this research is to develop and evaluate methods for conducting cluster randomised
trials in a primary care database that contains electronic patient records for large numbers of family practices.
Cluster randomised trials are trials in which the units allocated represent groups of individuals, in this case family
practices and their registered patients. Cluster randomised trials often suffer from the limitation that they include
too few clusters, leading to problems of insufficient power and only imprecise estimation of the intraclass
correlation coefficient, a key design parameter. This difficulty might be overcome by utilising databases that already
hold electronic patient records for large numbers of practices. The protocol describes one application: a study of
antibiotic prescribing for acute respiratory infection; a second protocol outlines an intervention in a less frequent
chronic condition of public health importance, stroke.
Methods/Design: The objective of the study is to implement a cluster randomised trial to test the effectiveness of
an electronic record-based intervention at achieving a reduction in antibiotic prescribing at consultations for
respiratory illness in patients aged 18 and 59 years old in intervention family practices as compared with controls.
Family practices will be recruited from the practices that presently contribute data to the UK General Practice
Research Database (GPRD). Following randomisation, electronic prompts will be installed remotely at intervention
practices to promote adherence with evidence-based standards of medical practice. The intervention was
developed through qualitative research at non-intervention practices. Data for outcome assessment will be
obtained from anonymised electronic patient records that are routinely collected into GPRD. This protocol outlines
the proposed study designs, data sources, sample size requirements, analysis methods and dissemination plans.
Ethical issues are also discussed.
Discussion: Results from this study will provide methodological evidence concerning the use of electronic patient
records and databases for implementing cluster randomised trials in primary care. The study will also provide
substantive findings in respect of electronic record-based interventions to reduce antibiotic prescribing in primary
care.
Trial Registration: Current Controlled Trials ISRCTN 47558792.
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This protocol aims to develop an application of electro-
nic patient records to the evaluation of health interven-
tions, including their health impacts and effectiveness.
We aim to provide ‘p r o o fo fc o n c e p t ’ of the feasibility
and utility of implementing cluster randomised trials
utilising electronic patient records in a large national
primary care database. The specific objectives of the
proposal are to develop, and confirm the feasibility of, a
resource efficient method for implementing cluster ran-
domised trials in public health and health services
research by implementing a cluster randomised trial in a
primary care database using routinely collected electro-
nic patient records to evaluate patient outcomes. There
will be two interventions that will build on our previous
research; one application is in a common acute condi-
tion - antibiotic prescribing in respiratory illness; the
other is in a less frequent chronic condition of public
health importance - stroke. This protocol only concerns
the intervention on antibiotic prescribing in respiratory
illness. The research will provide guidance for the future
conduct of cluster randomised trials using electronic
patient records.
In cluster randomised trials, entire areas or health ser-
vice organisational units are allocated to intervention or
control groups, with outcomes evaluated for individuals
within each cluster [1]. Cluster randomised trials (CRTs)
are increasingly utilised in public health and health ser-
vices research and are especially important in the eva-
luation health service and public health interventions
[2]. CRT designs may be used to avoid problems of con-
tamination. CRTs also facilitate pragmatic evaluation of
the effectiveness of interventions delivered in routine
practice settings. In addition, CRTs allow estimation of
cluster level elements associated with the efficacy of the
intervention. However, compared with studies in which
an equivalent number of individual subjects are allo-
cated, CRTs generally have reduced power because of
the correlation of individual responses within clusters.
The extent of such clustering is not easy to anticipate
[1]. Another difficulty is that only small numbers of
c l u s t e r sm a yb ea l l o c a t e di nC R T sb e c a u s er e c r u i t i n g ,
intervening in, and collecting data from clusters may be
costly [3].
In this proposal, we suggest that these difficulties may
be overcome, to a certain extent, by implementing CRTs
within the General Practice Research Database (GPRD),
a primary care database that includes records from large
numbers of practices. The database will provide a sam-
pling frame for the study, it will also provide a mechan-
ism for the electronic capture of data that describes
case-mix at baseline and outcome measures pre- and
post-intervention. This will be done by randomising,
intervening in, and analysing data from family practices
already contributing their electronic patient records to
the database. The GPRD offers an excellent pre-existing
sampling frame with large numbers of practices covering
5% of the UK population [4,5]. Studies conducted in the
GPRD should have good external validity, covering a
range of geographical and demographic settings and
levels of risk. The GPRD also offers ongoing data collec-
tion for baseline and outcome measures for all regis-
tered patients, offering the potential to implement
studies with greater power at lower cost. GPRD can
now be linked individually and anonymously to other
National Health Service (NHS) datasets. Currently, 304
GP practices in England are participating in this linkage
(about 50% of GPRD). Data from the Hospital Episode
Statistics (HES) and National Death Certificates (with
date and primary and secondary cause of death) will be
used for this study.
The substantive application for the research is in anti-
biotic prescribing. The problem of resistance to antimi-
crobial drugs is growing and appropriate prescribing of
antimicrobial drugs is of great public health importance
[6]. Respiratory tract infections (RTI) account for some
300-400 consultations annually per 1000 registered
patients [7] and up to 60% of all antibiotic prescribing
in family practice [6]. Giving antibiotics to patients with
RTIs is often motivated by a concern to meet patient
expectations [8] but antibiotics do not provide clinical
benefit in a majority of RTIs [6,9-11]. These illnesses
are usually brief and self-limiting, complications are
unusual even without antibiotics, [6,12] and antibiotics
may promote the spread of resistant organisms [13].
GPRD-based research has shown that antibiotic pre-
scribing for respiratory infections in primary care
declined between 1995 and 2000, [7,14] but since 2000
antibiotic prescribing for respiratory illness has stabilised
[15]. There is a need to develop and implement inter-
ventions that endorse evidence-based antibiotic prescrib-
ing in family practice [6]. The age range 18 to 59 has
been selected for study because the perceived, and
actual, risk of serious infective complications is lower
than at the extremes of age.
Methods/Design
Objective
To implement a cluster trial in GPRD in a common
acute condition. This study aims to test the effectiveness
of an electronic record-based intervention at achieving a
reduction in antibiotic prescribing at consultations for
respiratory illness in patients aged 18 and 59 years in
intervention practices as compared with controls.
Practices and allocation
Practices are being recruited through a letter of invita-
tion from GPRD. A record will be maintained of the
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lysed. Since data for all practices are collected into
GPRD, it will be feasible to compare participating and
non-participating practices through analysis of anon-
ymised data in GPRD.
GPRD practices are allocated by minimisation, stratify-
ing for region and list size. Allocation is at KCL to
ensure allocation is separated from the process of prac-
tice recruitment. Patients will be all registered patients
aged 18 to 59 years. There will be no other exclusion
criteria, so as to optimise both internal and external
validity [16].
Intervention
Electronic prompts have been developed based on
recommended clinical practice guidelines to be activated
during consultations for RTI in the selected age range.
The electronic prompts promote no antibiotic prescrib-
ing, or delayed antibiotic prescribing, instead of the
immediate prescription of antibiotics for respiratory
tract infections. The prompts specifically incorporate
recommendations from the recent NICE guidelines on
antibiotic prescribing in respiratory illness [6]. The
research also builds on existing work that has identified
barriers to reducing antibiotic prescribing [17-19] by
designing prompts that briefly address common con-
cerns (e.g. including messages providing evidence
regarding likely consequences of delayed prescribing or
not prescribing). During consultations with patients pre-
senting with symptoms of respiratory tract infection,
primary care professionals will see the prompts which
remind them of recommended standards of care in RTI.
The prompts will also provide them with supporting
information and links to evidence that supports the
recommendations, in a format suitable for printing out
for patients when appropriate. The decision on whether
to follow the treatment suggestions included in the
prompt will be at the discretion of the GP. The GP will
also be able to terminate display of the prompt at any
time. There will be no intervention at control practices.
The intervention phase will continue for 12 months at
each practice.
The VISION software used by GPRD practices does
not presently include any reminders on antibiotic pre-
scribing, so the trial will compare outcomes associated
with the new prompts as compared with care with no
prompts.
Intervention development
Intervention requires the development of prompts that
encourage primary care professional adherence with
recommended processes of care. The first year of the
project has included a workstream to develop appropri-
ate interventions consistent with the initial phases of the
MRC framework for complex evaluations [20]. The for-
m a ta n dc o n t e n to ft h em e s s a g e st ob eu s e di nt h e
interventions have been developed by a multi-disciplin-
ary grouping comprising the research team and primary
care professionals. Interventions are grounded in theore-
tical models of behaviour change [21,22] and informed
by pre-existing evidence including systematic reviews
[23,24] and national clinical guidelines as well as quali-
tative research. The development process was used to
explore the extent to which electronic prompts can be
used not only to remind GPs of recommended beha-
viour but also to convince them it will be beneficial and
assist them with implementation. Tape-recorded inter-
views were carried out with a maximum variety sample
of GPs (N = 30) from local non-GPRD practices with a
variety of characteristics, to identify factors likely to
influence successful implementation, and to pilot mes-
sages that have been identified as most likely to posi-
tively influence prescribing behaviour [25]. Thematic
analysis was used to determine the range of likely
responses to the proposed intervention and messages,
which were then iteratively modified as necessary. The
development and design of the prompts are reported in
detail by McDermott et al. [25]
Intervention implementation
Prompts will be downloaded automatically through the
DXS Point-of-Care system. DXS (UK) Ltd collects data
on usage of the information provided. In order to
understand utilisation of the intervention, we will ana-
lyse fully anonymised practice-level data on usage of the
electronic prompts that comprise the intervention.
Initial evaluation has shown that GPs may either begin
their record of the consultation by initiating an antibio-
tic prescription, or by recording a medical code consis-
tent with respiratory tract infection. The prompts are
designed to be sufficiently flexible to be activated either
by the start of an antibiotic prescription or by the speci-
fication of a medical code. ‘Antibiotics’ are defined as
including all drugs in section 5.1 of the British National
Formulary with the exception of anti-tuberculous and
anti-leprotic drugs. Initially, prompt activation will be by
means of medical codes.
Outcomes and analysis
Outcome evaluation will be through analysis of routi-
nely-collected GPRD data during a defined study period,
while historical information will be used to assess the
baseline characteristics of the study patients. Informa-
tion routinely collected into GPRD for all registered
patients includes medical history, use of medicines, hos-
pitalisations and other resource use, smoking history,
laboratory tests, letters from specialists or hospitals.
GPRD also now links patients in GPRD to the English
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date, duration and reason for hospitalisation. Availability
of data for all registered patients has potential to mini-
mise biases from patient selection/recruitment.
Electronic patient records will be eligible for trial ana-
lyses if they describe patients who consult with acute
respiratory tract infections, defined using pre-specified
Read codes that identify conditions appropriate for
study, and are aged 18 to 59 years at the date of the
consultation. Pre-intervention GPRD analyses have
already been reported [15]. Medical codes have been
selected for RTIs including sub-groups of colds, rhinitis
and upper respiratory infection; sore throat, pharyngitis
and tonsillitis; influenza; laryngitis and tracheitis includ-
ing croup and epiglottitis; acute sinusitis; otitis media
and earache; acute bronchitis; and chest infection and
pneumonia. The primary outcome will be the propor-
tion of RTI consultations with antibiotics prescribed
over 12 months; secondary outcomes will be age- and
sex-specific rates of RTI consultation, age and sex-speci-
fic proportion of RTI consultations with antibiotics pre-
scribed, and occurrence of RTI complications. We will
use linked Hospital Episode Statistics (HES) data for
English practices to evaluate hospitalisation with respira-
tory illness. Analyses will also be reported separately for
each sub-group of RTI codes. In order to provide
further insight into safety issues, family practices will be
offered the opportunity to notify the study team pro-
spectively of suspected adverse events, in fully anon-
ymised format, during the course of the trial.
Outcomes will be measured through analysis of GPRD
electronic prescribing records as described previously
[14]. Antimicrobial drugs included will be those in Brit-
ish National Formulary chapter 5.1 excluding anti-tuber-
culous and anti-leprotic drugs. A maximum of one RTI
consultation and antibiotic prescription on the same day
will be analysed. Only first consultations within the
same episode will be evaluated for the primary outcome,
using a 10 day time window. Data for the intervention
phase of the trial will be analysed from the intervention
start date to 12 months later. Trial analyses will estimate
the difference (95% confidence interval) in the propor-
tion of RTI consultations with antibiotics prescribed
between intervention and control groups after adjusting
for age-group, sex, pre-intervention prescribing propor-
tion. A cluster-level analysis will be implemented using
the practice specific proportions as observations, with
minimum variance weights to allow for varying numbers
of consultations per practice [26].
Sample size calculation
The sample size calculation is based on a comparison
between the intervention condition, in which the new
prompts are present, and usual care, in which no
prompts are present. A cluster-level analysis of the prac-
tice specific proportions will be implemented. The sam-
ple size calculation therefore estimates the number of
clusters (practices) required for the study. In a systema-
tic review, quality improvement interventions were asso-
ciated with reductions in antibiotic prescribing of
between 7% and 12% (Ranji et al., 2006). The study
therefore aims to detect differences of less than 7%. The
selected age-range comprises about 55% of the regis-
tered population with about 1,000 registered patients
per general practitioner and about 4,500 patients per
practice. In data from Gulliford et al. [15], the age-stan-
dardised rate of RTI consultations in the 18 to 59 years
range was 280 per 1,000 in women and 146 per 1,000 in
men in 2006. This suggests there will be about 959 RTI
consultations per year, per practice. We observed 1166
consultations in 5,647 person years, [15] consistent with
932 consultations per year per practice. Assuming 10%
of consultations may be second visits, there may be 850
eligible consultations per practice. The proportion of
consultations with antibiotics prescribed in 2006 was
approximately 39% for all RTIs, having declined from
44% in 1997 (unpublished data). We assume that the
coefficient of variation of this proportion between prac-
tices is 0.23 from Ashworth et al. [14], with alpha = 0.05
and power = 0.8. From Hayes and Bennett [27] equation
4, to detect a 5% difference in the proportion of consul-
tations at which antibiotics are prescribed, 47 practices
per group will be required. To detect a 6% difference 32
practices per group will be required. The GPRD
includes more than 400 practices and a recent question-
naire of 386 GPRD practices found that 68% (262) were
interested in participating in clinical trials. We plan to
include 50 practices per group.
Research ethics and governance
Hutton [28] suggests that consent in a cluster trial may
be sought for three main reasons:
i) for the use of routinely held data;
ii) for the collection of additional data specifically for
the study;
iii) for the offer or administration of an intervention.
The practices included in the present research already
contribute anonymised electronic patient records to
GPRD under an established governance framework. No
additional data will be collected for this study at the
individual patient level.
Implementing the interventions will require the rando-
misation of practices that are already participating in
GPRD. Edwards et al. [29], and MRC [30] guidance on
cluster randomised trials, distinguish two types of clus-
ter randomised trials. Type A (or cluster-cluster) inter-
ventions are implemented for the whole cluster and
consent is required at the cluster level from a guardian
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individual) interventions that are implemented at the
individual participant level. These require active recruit-
ment of individual participants within practices with a
requirement for informed consent at the individual par-
ticipant level. In Type B studies, selection of individual
participants subsequent to the randomisation of the
cluster may represent a potentially serious form of bias.
In the proposed research covered by this application,
the trial intervention will be implemented at the cluster
(practice) level through a modification to the practice
information system. In trials of cluster-level interven-
tions, consent should be obtained from the guardian of
the cluster (usually the senior partner) on behalf of the
cluster members (registered patients) [29,30]. The guar-
dian’s consent is regarded as ethically justified if the
expected utility associated with the trial intervention is
greater than the alternative [29]. The proposed interven-
tions will encourage primary care professionals to
adhere to nationally agreed, evidence-based, standards
of care. Electronic prompts will provide practitioners
with additional information during the course of consul-
tations. However, all clinical treatment decisions remain
at the discretion practitioners and their patients.
Although electronic prompts provide information and
advice concerning recommended standards of care,
practitioners and patients remain free to jointly negoti-
ate a chosen course of action during each consultation.
Analysis of outcomes will be through the analysis of
routinely collected and anonymised GPRD data at the
individual patient level.
We have convened a Trial Steering Committee (TSC)
and a Data Monitoring and Ethics Committee (DMEC)
with Independent Chairs and two/three independent
members for each committee. The study was approved
by London Surrey Borders Research Ethics Committee
(09-H0806-81) and by the MHRA Independent Scienti-
f i cA d v i s o r yC o m m i t t e eo nD a t a b a s eR e s e a r c h( I S A C )
(08-083).
Discussion
Anticipated outcomes
This study will provide evidence concerning the feasibil-
ity of implementing CRTs using the electronic records
of patients with both acute conditions. The research will
specifically provide evidence concerning the effective-
ness of a strategy based on electronic prompts at enhan-
cing effectiveness of care.
Evaluation
As these studies will be among the first intervention stu-
dies implemented within GPRD, evaluation of the obsta-
cles, barriers and facilitators to implementation of
intervention research within GPRD will be an integral
part of the study. We will evaluate views of staff at
GPRD and practices using a questionnaire to ensure the
anonymity of practices is maintained. Towards the end
of the trial, an invitation email to complete an electronic
evaluation questionnaire will be sent to all practices
(both control and intervention groups). Fidelity of
adherence with the intervention protocol, as well as fea-
sibility and acceptability of interventions and trial parti-
cipation, will be specifically addressed. Quantitative data
will be supplemented by telephone interviews with a
purposive sample to explore experiences of the interven-
tion in more depth.
Reporting, dissemination and implementation
We will prepare interim reports as well as an end-of pro-
ject report. We expect to publish our findings in peer-
review journals and make presentations at scientific
meetings and conferences. The methodology developed
through this project will have wide potential for applica-
tion in future research and we expect that dissemination
efforts will also be facilitated by data providers including
GPRD and other databases. A key output from the
research will therefore be methodological advice that will
identify and analyse the component tasks of implement-
ing a cluster trial through electronic patient records.
Limitations
We recognise that the study will have limitations both
with respect to the feasibility of the research and the
validity of the results. One of the main purposes of the
research is to evaluate the feasibility of conducting clus-
ter trials in an electronic database. We will therefore
document and report the processes of research that
either facilitate or impede the conduct of these cluster
trials. Cluster trials are susceptible to bias. However, the
implementation of a cluster trial within an electronic
database offers the opportunity to evaluate such biases
because data may be analysed both for participating and
non-participating practices. For example, the behaviour
of professionals at control practices may be modified
through their participation in the study even though
they are not exposed to the intervention. This potential
bias may be evaluated by comparing changes in practice
at non-participating practices and participating control
practices.
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